We are live on
!
Find out more
SW
SVB Wealth Portfolio holdings
AUM
$1.59B
1-Year Est. Return
24.57%
This Fund
S&P 500
This Quarter
Est. Return
+10.57%
1 Year Est. Return
+24.57%
3 Year Est. Return
+170.11%
5 Year Est. Return
+215.35%
10 Year Est. Return
+575.69%
AUM
$5.53B
AUM Growth
-$1.62B
(-23%)
Cap. Flow
-$2.09B
Cap. Flow
% of AUM
-37.72%
Top 10 Holdings %
Top 10 Hldgs %
38.69%
Holding
1,058
New
42
Increased
159
Reduced
670
Closed
121
Top Buys
| 1 |
Pfizer
PFE
|
+$8.23M |
| 2 |
SLB Ltd
SLB
|
+$7.4M |
| 3 |
DraftKings
DKNG
|
+$2.65M |
| 4 |
RC
Ready Capital
RC
|
+$2.32M |
| 5 |
International Flavors & Fragrances
IFF
|
+$792K |
Top Sells
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$169M |
| 2 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$166M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$160M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$137M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$118M |
Sector Composition
| 1 | Technology | 18.67% |
| 2 | Communication Services | 9.26% |
| 3 | Healthcare | 8.33% |
| 4 | Financials | 5.7% |
| 5 | Industrials | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Atara Biotherapeutics
ATRA
$76.8M
| $285K | 0.01% |
7,075
| – | – |
|
652
PACCAR
PCAR
$66.5B
| $284K | 0.01% |
3,390
-432
| -11% | -$32K |
|
653
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $282K | 0.01% |
2,924
-257
| -8% | -$25.3K |
|
|
MPT
654
Medical Properties Trust
MPT
$2.82B
| $282K | 0.01% |
30,449
-16,175
| -35% | -$137K |
|
655
iShares ESG Advanced MSCI EAFE ETF
DMXF
$1.19B
| $282K | 0.01% |
4,622
-28
| -0.6% | -$1.7K |
|
|
BERY
656
DELISTED
Berry Global Group, Inc.
BERY
| $281K | 0.01% |
4,749
-965
| -17% | -$52.7K |
|
657
ITT
ITT
$17.2B
| $280K | 0.01% |
3,009
-183
| -6% | -$15.4K |
|
658
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.81B
| $280K | 0.01% |
2,610
-104
| -4% | -$10.6K |
|
659
C.H. Robinson
CHRW
$24.4B
| $279K | 0.01% |
2,958
+176
| +6% | +$17K |
|
660
CRH
CRH
$68.8B
| $279K | 0.01% |
5,004
-352
| -7% | -$17.6K |
|
661
MSCI
MSCI
$45.8B
| $278K | 0.01% |
593
-92
| -13% | -$44.9K |
|
662
Sumitomo Mitsui Financial
SMFG
$159B
| $278K | 0.01% |
32,303
+563
| +2% | +$4.65K |
|
663
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
| $276K | 0.01% |
5,850
| – | – |
|
664
Sixth Street Specialty
TSLX
$1.66B
| $274K | ﹤0.01% |
+14,649
| New | +$267K |
|
665
Wipro
WIT
$18.4B
| $273K | ﹤0.01% |
115,756
+29,968
| +35% | +$69.7K |
|
666
Ventas
VTR
$46.5B
| $273K | ﹤0.01% |
5,773
-1,577
| -21% | -$71.5K |
|
667
Diamondback Energy
FANG
$54.7B
| $272K | ﹤0.01% |
2,072
-214
| -9% | -$28.6K |
|
668
Franklin Resources
BEN
$17B
| $272K | ﹤0.01% |
10,180
-392
| -4% | -$10.1K |
|
|
TECX
669
Tectonic Therapeutic
TECX
$605M
| $270K | ﹤0.01% |
23,697
| – | – |
|
670
Trimble
TRMB
$12.5B
| $270K | ﹤0.01% |
5,102
-146
| -3% | -$7.14K |
|
671
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.41B
| $270K | ﹤0.01% |
5,938
| – | – |
|
672
Mitsubishi UFJ Financial
MUFG
$242B
| $269K | ﹤0.01% |
36,543
-1,954
| -5% | -$13K |
|
673
USA Compression Partners
USAC
$3.83B
| $265K | ﹤0.01% |
13,438
-1,191
| -8% | -$23.9K |
|
|
NAB
674
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
| $262K | ﹤0.01% |
29,903
+5,060
| +20% | +$44.4K |
|
675
CGI
GIB
$14.3B
| $261K | ﹤0.01% |
+2,475
| New | +$252K |
|
Similar funds
VNT
SIA
NCL
DG
GWANC
SS
LCM
LDB
SVB Wealth's Q2 2023 Portfolio in Review
As of Q2 2023, SVB Wealth held 1,058 positions worth $5.53B, down 23% from $7.16B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
SVB Wealth withdrew a net $2.09B in Q2 2023, closing 121 positions and reducing 670 holdings. Its most notable exit was Workiva, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, SVB Wealth opened a new position in DraftKings worth $3.06M.
- SVB Wealth's largest Q2 2023 buy was DraftKings: 115,043 shares worth $3.06M.
- SVB Wealth added most to Pfizer in Q2 2023, an estimated $8.23M increase.
- SVB Wealth's biggest Q2 2023 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $169M.
- SVB Wealth fully exited Workiva in Q2 2023, selling an estimated $10.3M.
- SVB Wealth's ten largest holdings make up 39% of its $5.53B portfolio in Q2 2023.
- SVB Wealth opened 42 new positions and closed 121 in Q2 2023.
- SVB Wealth's portfolio value fell 23% quarter-over-quarter to $5.53B.
Based on SVB Wealth's 13F filing for Q2 2023, filed 24 Jul 2023.